Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

405.25
Delayed Data
As of Aug 24
 -15.36 / -3.65%
Today’s Change
329.09
Today|||52-Week Range
592.59
-25.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues1.1B1.1B1.2B1.2B
 
 
 
 
 
Cost of Goods Sold109.1M110.8M111.8M69.0M
 
 
 
 
 
Depreciation And Amortization20.7M22.9M23.0M25.0M
 
 
 
 
 
 
Operating ExpensesGross Income1.0B964.3M1.1B1.1B
 
 
 
 
 
General Expenses615.2M756.2M736.8M826.9M
 
 
 
 
 
Research And Development405.3M461.2M447.1M534.9M
 
 
 
 
 
Total Operating Expenses745.0M889.9M871.5M921.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income392.4M208.2M329.3M291.6M
 
 
 
 
 
Extraordinary Charge-21.0K-1.9M0.00--
 
 
 
Interest Expense On Debt1.7M3.6M1.4M2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income393.3M227.3M330.2M292.3M
 
 
 
 
 
Income Taxes-182.9M-72.3M-164.4M-96.0M
 
 
 
 
 
Net Income210.4M155.0M165.7M196.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS103.3M103.8M104.3M104.6M
 
 
 
 
 
Shares To Calculate EPS Diluted115.9M115.5M114.2M116.2M
 
 
 
 
 
 
Earnings Per ShareEPS$1.82$1.34$1.45$1.69
 
 
 
 
 
EPS Diluted$1.82$1.34$1.45$1.69